retatrutide trial results news ⭐️topline from TRIUMPH-1, a Phase 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with obesity or “overweight” VisualAbstract: Retatrutide reduces body weight

Demi Buckley initially tried to lose weight through diet and exercise, she said, but despite her efforts nothing worked

Groups of male mice (1213 weeks, 22.528.5 g, 56 mice/23 cages/group) were fasted for 4 h prior to IP injection of unfused WT albumin (0.9 mg/kg) or GLP-1 albumin fusions (1 mg/kg)

Yes, patients with type 2 diabetes should be monitored for hypoglycaemia, especially if taking insulin or sulfonylureas alongside Wegovy

Accessing an online prescription for GLP-1 and GIP in Ireland has never been more straightforward as long as you meet the medical criteria

Differential sensitivity to central leptin and insulin in male and female rats